© Reuters. FILE PHOTO: Boxes of Abbott’s heart stents are pictured inside a store at a hospital in New Delhi, India, April 27, 2018. Picture taken April 27, 2018. REUTERS/Adnan Abidi
(Reuters) – Abbott Laboratories (NYSE:) quarterly profit more than doubled on Thursday, due to strength in its diagnostics business and a rebound in medical devices sales.
The company’s net earnings rose to $1.19 billion, or 66 cents per share, in the second quarter ended June 30, from $537 million, or 30 cents per share, a year earlier.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.